Angiotensin Converting Enzyme Gene Insertion/Deletion Polymorphism (rs4646994) in Acute Coronary Syndrome
Keywords:
Acute Coronary Syndrome, ACE Gene, Polymorphism, Genetic Risk, South India, Genotype, Cardiovascular DiseaseAbstract
Introduction: Acute coronary syndrome (ACS) is a leading cause of death in India and is affected by both genetic and environmental factors. The angiotensin-converting enzyme (ACE) gene’s insertion/deletion (I/D) polymorphism (rs4646994) has been linked to cardiovascular risk, but its connection to ACS in South Indian populations is not well studied. This case-control study aimed to explore this relationship by comparing 81 ACS patients with 81 matched controls.
Material and Methods: Genotyping was done using PCR and Sanger sequencing. We analyzed genotype and allele frequencies with chi-square tests and logistic regression.
Results: Among patients, the genotype distribution was 29.6% II, 51.9% ID, and 18.5% DD. In contrast, controls had 45.7% II, 43.2% ID, and 11.1% DD. We did not find any significant difference in genotype frequencies (p > 0.05). However, logistic regression showed that the ID genotype was linked to a lower risk of ACS (OR = 0.50, 95% CI = 0.75–4.43, p = 0.02). The DD genotype did not show a significant connection (p = 0.13). The dominant model (ID+DD vs II) indicated an increased ACS risk (OR = 1.99, 95% CI = 1.04–3.81, p = 0.02). Overall, the ACE I/D polymorphism did not show a consistent link to ACS in this group, which may reflect genetic diversity in the region.
Conclusion: Our study found no consistent overall association between ACE I/D polymorphism (rs4646994) and ACS, though the ID genotype appeared protective and the dominant model (ID+DD) suggested increased risk. These findings indicate a possible role of ACE polymorphism in ACS susceptibility among South Indians, warranting larger multicenter studies for confirmation.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 JK Science: Journal of Medical Education & Research

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.



